secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001193125-22-171921
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma reports 2022 annual meeting voting results
--------------------------------------------------------

- All seven director nominees elected (Driscoll, Fletcher, Gray, Howson, Kiener, Morich, Passeri).
- Ratification of RSM US LLP as independent auditor for FY 2022 approved with 26,125,468 votes for.
- Broker non-votes of 14,293,960 on director elections; no other proposals were voted on.
- Meeting held June 9, 2022; results filed on June 10, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522171921/0001193125-22-171921-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000119312522171921/d370247d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171921

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer